Merja Haaparanta-Solin
Adj.prof.

Adjunct Professor
Senior Research Fellow, PET Basic Operations (Turku PET Centre)
MediCity Research Laboratories, PET
merja.haaparanta-solin@utu.fi
+358 29 450 3837
+358 50 356 2845

Tykistökatu 6
Turku





Publications
Go to first page Go to previous page 5 of 5 Go to next page Go to last page

In vivo sampling for pharmacokinetic studies in small experimental animals: A combination of microdialysis, planar chromatography and digital autoradiography (2004) Haaparanta M, Gronroos T, Marjamaki P, Eskola I, Bergman J, Paul R, Solin O
(
A1 Journal article – refereed)

Radiochemical purity analysis of F-18-labelled tracers: Comparison of a TLC-scanner, film autoradiograhy and digital autoradiography (2004)
European Journal of Nuclear Medicine and Molecular Imaging
Kamarainen EL, Haaparanta M, Kyllonen T, Siitari-Kauppi M, Lipponen T, Bergstrom K, Solin O
(
A1 Journal article – refereed)

Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ) (2004) Solin O1, Eskola O, Hamill TG, Bergman J, Lehikoinen P, Grönroos T, Forsback S, Haaparanta M, Viljanen T, Ryan C, Gibson R, Kieczykowski G, Hietala J, Hargreaves R, Burns HD
(
A1 Journal article – refereed)

Microdialysis and 2-[F-18]fluoro-2-deoxy-D-glucose (FDG): A study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue (2003)
Life Sciences
Haaparanta M, Paul R, Gronroos T, Bergman J, Kamarainen EL, Solin O
(
A1 Journal article – refereed)

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome (2000)
Neurology
Ruottinen HM, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O, Rinne JO
(
A1 Journal article – refereed)

Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study (2000)
Archives of Neurology -Chigago-
Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O
(
A1 Journal article – refereed)

High levels of dopamine activity in the basal ganglia of cigarette smokers (2000)
American Journal of Psychiatry
Salokangas RKR, Vilkman H, Ilonen T, Taiminen T, Bergman J, Haaparanta M, Solin O, Alanen A, Syvalahti E, Hietala J
(
A1 Journal article – refereed)

Prediction of detached personality in healthy subjects by low dopamine transporter binding (2000)
American Journal of Psychiatry
Laakso A, Vilkman H, Kajander J, Bergman J, Haaparanta M, Solin O, Hietala J
(
A1 Journal article – refereed)

Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT (2000)
Annals of Neurology
Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO
(
A1 Journal article – refereed)

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography (2000)
American Journal of Psychiatry
Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Rakkolainen V, Syvalahti E, Hietala J
(
A1 Journal article – refereed)

Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy (1999)
Circulation
Laine H, Katoh C, Luotolahti M, Yki-Jarvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J
(
A1 Journal article – refereed)

Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease (1999)
Journal of Neurology, Neurosurgery and Psychiatry
Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P, Solin O
(
A1 Journal article – refereed)


Last updated on 2019-23-08 at 02:19